A 2.3-kb cDNA clone encoding Aleutian mink disease parvovirus (ADV) structural proteins VP1 and VP2 was inserted into the polyhedron gene of Autographa calijbmica nuclear polyhedrosis virus (AcNPV) and expressed by the recombinant virus, AcADV-1, in Spodoptera frugiperda-9 cells. Sodium dodecyl sulfatepolyacrylamide gel electrophoresis and western immunoblot analysis (WIA) indicated that synthesis of both VP1 and VP2 was being directed by AcADV-1. Fluorescence microscopic examination of AcADV-1 -infected S. frugiperda-9 cells indicated that the recombinant protein was present within the nucleus of the cells, and electron microscopic examination of these cells revealed the presence of small particles 23-25 nm in diameter. Structures resembling empty ADV capsids could be purified on CsCl density gradients, thus indicating that the ADV proteins were self-assembling. The antigenicity of recombinant VP1 and VP2 was evaluated by WIA. Sera collected from 16 mink prior to infection with ADV did not react with VP1 and VP2. Ten sera collected from mink with counter current immunoelectrophoresis (CIE) titers greater than 4 (log 2 ) reacted with VP1 and VP2 in WIA. Two of 6 sera with CIE titers of 4 and 1 of 14 sera with CIE titers <4 reacted with the recombinant proteins. These results suggest that baculovirus recombinant ADV capsid proteins may be useful as diagnostic antigens.
have the gene for the Aleutian coat color. Aleutian Aleutian disease of mink (AD) is caused by the autonomous parvovirus, Aleutian mink disease parvovirus (ADV). 6 First described in 1956, 15 AD is responsible for significant economic loss in commercial mink ranching operations. 1, 14 The infection in adult mink is persistent and is characterized by plasmacytosis, hypergammaglobulinemia, and ultimately immune complex mediated glomerulonephritis and arteritis. 12, [18] [19] [20] [21] Newborn mink kits without maternal antibodies usually develop an acute fulminant, fatal respiratory distress syndrome characterized by interstitial pneumonia and the formation of hyaline membranes. 3, 4, 16 The disease is most severe in mink that been unsuccessful. Consequently, the disease is controlled in mink populations by serologically identifying and subsequently removing infected mink. 1, 17 Experimental studies have demonstrated that detectable levels of IgM antibody appear within 6 days after infection and can persist for at least 85 days. 5,21 Detectable levels of IgG antibody usually appear within 10-15 days of infection and will persist for the life of the mink.6 ,17 These immunoglobulins show reactivity for the capsid proteins VP1 and VP2 and the nonstructural proteins NS-1 and NS-2. 1 The most commonly used serologic tests for detection of anti-ADV antibody are counter current immunoelectrophoresis (CIE) 10,7 and indirect counter genotype mink usually die within 12-16 weeks after mink generally occurs by 26-30 weeks after infection, infection. In contrast, 50% mortality for non-Aleutian depending upon virus strain. 12, 13 current electrophoresis. 2 These assays require a highly tigen for these assays has been produced in cell culture purified ADV antigen preparation. Traditionally, anor extracted from tissues of infected mink. 7 Although neutralizing antibody can be demonstrated in vitro, attempts to prevent AD by vaccination have More recently, ADV capsid proteins were expressed by developing a recombinant vaccinia virus. This recombinant virus contains a 2.3-kb cDNA insert that contains the complete coding sequence for VP1 and VP2. 9 The ADV proteins in this construction are of From the Department of Microbiology, Immunology and Pre-the same size as native ADV proteins, are transported ventive Medicine, Iowa State University, Ames, IA 50011 (Wu, to the nucleus of the infected cell, and self-assemble McGinley, Platt) , and the Laboratory of Persistent Viral Diseases, National Institute of Allergy and Infectious Diseases, National In-into empty particles with the same physicochemical stitutes of Health, Rocky Mountain Laboratories, Hamilton, MT characteristics as empty ADV virions. Cell lysates con-59840 (Bloom, Berry). taining these recombinant capsids can substitute for Received for publication February 22, 1993. commercial ADV test antigens in CIE. However, the 23 potential use of these materials is limited because of the presence of infectious vaccinia virus in the preparations.
In the present study, the ADV capsid protein coding sequence was inserted into the baculovirus Autographa californica nuclear polyhedrosis virus (AcNPV) to derive the recombinant baculovirus AdADV-1, which directed synthesis of ADV capsid proteins. Large quantities of both VP1 and VP2 were expressed and were shown to be immunologically reactive in the western immunoblot assay (WIA).
Materials and methods
Cells and virus. The wild-type Autographa californica nuclear polyhedrosis virus (AcNPV) a and recombinant baculovirus stocks were propagated in Spodoptera frugiperda-9 (Sf-9) cell cultures a maintained at 28 C in tetranitromethane (TNM)-FH medium prepared by supplementing Grace medium b with 0.3% yeastolate, 0.3% lactalbumin hydrolysate, gentamicin (50 &ml), amphotericin B (2.5 &ml), and 10% fetal calf serum. The ADV-G strain of ADV and the ADV expressing recombinant vaccinia virus VV:IL1 was propagated in Crandell feline kidney (CRFK) and CV-1 cells, respectively, as previously reported. 9 Constructions of recombinant plasmid. A 2.3-kb Bgl 2 cDNA fragment containing the coding sequences for the ADV capsid proteins VP1 and VP2 was released from vector sequences and ligated into the Bgl 2 site of the baculovirus transfer plasmid pVL1392 c downstream from the polyhedrin gene promoter. This recombinant transfer plasmid was then transformed into Escherichia coli NM522. a Clones containing the ADV cDNA were identified by colony hybridization with the ADV cDNA insert labeled with 32 P to a specific activity of 7 x 10 7 dpm/µg by random hexamer priming using a DNA labeling kit. d A recombinant plasmid (pVLADVS) containing the insert in the correct transcriptional orientation was identified by restriction enzyme analysis and subsequently propagated. Plasmid DNA was isolated by affinity chromatography using a commercial plasmid kit e and was used to produce recombinant baculovirus.
Production and identification of recombinant baculovirus. One microgram of purified wild-type AcNPV DNA and 2 µg of pVLADVS DNA were mixed in 0.75 ml of transfection buffer, pH 7.1 (25 mM Hepes, 140 mM NaCl, 125 mM CaCl,). This mixture was then added to a 25-cm 2 flask containing 2 x 10 6 Sf-9 cells that were seeded 1 hr previously and subsequently maintained at 28 C for 4 hr. The cells were then rinsed with TNM-FH and incubated in fresh TNM-FH for 5 days at 28 C. At the end of this period, culture medium was collected and screened for recombinant baculovirus by a dot-blot hybridization procedure as described previously. ll Sf-9 cells were seeded into 96-well microplates at a density of 2 x 10 6 cells/well in a volume of 100 µl of TNM-FH. Individual wells were then inoculated with 50 µ1 of 10-fold dilutions of medium containing potential recombinant baculovirus and incubated at 28 C. Six days later, all medium that contained potential recombinant baculovirus was removed from each well, transferred to a duplicate microtiter plate, and stored at 4 C for future use. The cell monolayers in each well were then lysed with 200 µl of 0.5 N NaOH. Cell lysates were transferred to a nylon filter f using a dot-blot microfiltration apparatus. g All filters were previously rinsed with 0.5 N NaOH. Individual filters were subsequently washed with 200 µ1 of 0.5 N NaOH, removed from the apparatus, and treated for 2 hr at 65 C in 3 x SSPE (1 x SSPE consists of 0.18 M NaCl, 10 mM NaH 2 PO 2 H 2 O, 1 mM ethylenediaminetetraacetic acid [EDTA] containing 5 x Denhardt's solution, 0.1% sodium dodecyl sulfate (SDS), and 0.1 mg/ml salmon sperm DNA. Filters were subsequently hybridized with the 32 P-labeled 2.3-kb ADV cDNA insert overnight in the same buffer. Filters were then washed at 65 C for 30 min once in 2 x SSPE and once in 0.1 x SSPE that contained 0.1% SDS. Washed filters were exposed to radiographic film h at -70 C for 2 hr, which permitted the identification of wells that contained recombinant baculovirus.
Individual recombinant viruses were cloned from mixed populations of baculovirus by 4 subsequent rounds of limiting dilutions and identified as previously described. The homogeneity of the cloned populations was verified by thoroughly examining virus-infected Sf-9 monolayers for the presence of nuclear occlusions. The presence of occlusions would indicate contamination with nonrecombinant virus.
Expression and identification of AD V recombinant protein. Sf-9 cells in 25-cm 2 flasks were singly infected with wild-type AcNPC or recombinant baculovirus AcADV-1 at a multiplicity of infection (m.o.i.) of 10 and incubated at 28 C for 72 hr. Cultures were then harvested, and the cell pellets were solubilized by adding 100 µl of Laemmli sample buffer (50 mM Tris-HCl, pH 6.8, 1% SDS, 1% 2-mercaptoethanol, 0.1% bromophenol blue) to each 1 ml volume of original cell suspension that contained approximately 6 x 10 5 cells. The treated cell preparations were boiled for 10 min and electrophoresed through a 10% gel using SDS polyacrylamide gel electrophoresis (SDS-PAGE). The electrophoretically separated proteins were transferred from the gel to nitrocellulose membranes. The membranes were blocked by immersion in TBS (25 mM Tris, pH 7.5, 500 mM NaCl) containing 3% gelatin and then reacted with an optimal dilution of pooled sera from ADV-infected or noninfected mink. After washing with TBS containing 0.05% Tween 20, the ADV proteins were visualized by treating the membranes with horseradish peroxidase conjugated to protein A i and developing subsequently with the chromogen 4-chloro-1-naphthol. Both mink serum and the conjugate were diluted in TBS containing 1% gelatin.
Direct immunofluorescence. The intracellular location of recombinant ADV protein was demonstrated by immunofluorescence. Cultures of Sf-9 cells were infected with the recombinant baculovirus at an m.o.i. of 1 and incubated for 72 hr. Infected cells were collected and resuspended in TNM-FH with uninfected cells at a ratio of 1:3. Eight-well tefloncoated glass slides j were spotted with 5 µ1 of the cell suspensions. The cells were permitted to settle onto and adhere to the glass slides for 30 min. Cell monolayers were then fixed with acetone for 5 min at 4 C. The fixed cell preparations were overlaid with mink anti-ADV-specific IgG conjugated to fluorescein isothiocyanate c and incubated for 1 hr at 37 C in a humidified atmosphere. Slides were then washed 3 times by immersion in distilled water for 5 min each, air dried, and examined with a fluorescence microscope.
Electron microscopy. Sf-9 cells infected at an m.o.i. of 10 for 72 hr were collected and fixed with 2% glutaraldehyde prepared in phosphate-buffered saline (PBS). The fixed cells were washed twice in PBS and then stained with 1% osmium tetroxide in 0.1 M PBS, rinsed in distilled water, dehydrated with alcohol, infiltrated with propylene oxide, and embedded in epoxy resin. Sections with a thickness of 600-900 Å were collected onto bare 3-mm copper grids and stained with a solution containing 2% uranyl acetate diluted in methanol with Reynolds' lead acetate 22 and examined in an electron microscope.
Equilibrium density ultracentrifugation. Lysates of AcADV-1-infected Sf-9 cells were subjected to buoyant density gradient centrifugation as described previously. 9 Cell pellets from 5 150-cm2 flasks of AcADV-l-infected Sf-9 cells were suspended in 5 ml of PBS and lysed by freeze-thawing and sonication. Following clarification by centrifuging at 13,600 x g for 30 min at 4 C, the suspension was vortexed for 3 min with an equal volume of freon 113 and centrifuged as above. The aqueous supernatant was layered over a 2-ml cushion of 40% sucrose in PBS-0.1% sarkosyl and ultracentrifuged in an SW 27 rotor at 24,000 rpm for 44 hr and 20 min. The pellet was resuspended in a total of 5 ml Tris-EDTA-0.1% sarkosyl, and 2.39 g solid cesium chloride was added. The solution was ultracentrifuged in an SW, 41 rotor for 40 hr at 18 C at 28,000 rpm. Fractions (0.5 ml) were collected by puncturing the bottom of the tube, and the density was determined by measuring the refractive index. Aliquots of each fraction were absorbed onto parlodion-coated grids, washed with distilled water, stained with 0.5% uranyl acetate, and examined in an electron microscope. Preparations of ADV-G-infected CRFK cells or VV:ILl-infected CF-l cells were similarly treated.
Evaluation of the antigenicity of the recombinant protein. The antigenicity of ADV recombinant protein for mink was evaluated further by western immunoblot analysis as previously described using a panel of mink sera that represented pre-and postinfection sequential blood samples from 16 adult mink. c The antibody titers of these sera were previously determined by CIE and ranged from <4 (log 2 ) to 14 (log 2 ).
Results
Construction and isolation of a recombinant baculovirus. Successful insertion of genes into baculovirus involves recombination of foreign sequences into the polyhedrin gene of the wild-type baculovirus, AcNPV, and is characterized by inactivation of that nonessential gene. The loss of a functional polyhedrin gene can be assessed by a change in plaque morphology and loss of the 29-kD polyhedrin gene protein in lysates of infected cells.
A recombinant baculovirus transfer vector containing the complete coding sequences of the ADV VP1 and VP2 genes under the control of the AcNPV polyhedrin promoter was constructed ( Fig. 1) and denoted pVLADVS. Recombinant baculovirus was produced by the cotransfection of Sf-9 insect cells with wild-type AcNPV DNA and the transfer vector pVLADVS. Recombinant baculoviruses were identified by dot-blot hybridization (Fig. 2) and cloned by 4 rounds of limiting dilution. The effectiveness of cloning the recombinant virus was based on the absence of viral inclusions in cells infected with the cloned populations of recombinant baculovirus. A single clone, designated AcADV-1, was selected and used for studying the expression of ADV capsid proteins.
Expression of ADV capsid proteins in Spodoptera frugiperda cells. Sf-9 cells were infected at an m.o.i. of 10 with wild-type baculovirus AcNPV or the recombinant baculovirus AcADV-1. Infected cells were harvested at 72 hours postinfection and analyzed by SDS-PAGE and WIA. A representative coomassie bluestained gel is shown in Fig. 3 . The 29-kD polyhedrin protein present in solubilized wild-type AcNPV-infected cells, as indicated in lane 3, is not present in the lysate of recombinant baculovirus-infected Sf-9 cells, as indicated by the absence of a representative band in lane 2. The polyhedrin protein has been replaced by 2 proteins with molecular weights of approximately 85 kD and 70 kD, which are similar to the molecular weights of native VP1 (85 kD) and VP2 (75 kD). Neither the polyhedrin nor the 2 recombinant proteins were evident in total protein lysates of uninfected Sf-9 cells (lane 1).
To confirm the identity of the recombinant protein, WIA using sera from ADV-infected mink was per- formed on a similar set of samples (Fig. 4) . Comparison of lysates from AcADV-l-infected Sf-9 cells (lanes 2, 3) with ADV-G-infected CRFK cells (lane 1) revealed that both ADV capsid proteins VP1 and VP2 were being expressed by the recombinant baculovirus. In addition, smaller proteins with molecular masses of approximately 60 kD and 30 kD were noted. These proteins were not observed in AcNPV-l-infected Sf-9 cells (lane 4) nor in the uninfected CRFK cells (lane 5) and thus probably represented proteolytic breakdown products similar to those previously reported. 9
Intracellular location of ADV capsid proteins expressed in Sf-9 cells. ADV capsid proteins either from natural infections or from vaccinia expression systems accumulate in the nucleus of infected cells. To determine if the ADV capsid proteins expressed by AcADV-1 also accumulated in the nucleus of the Sf-9 insect cells, we examined infected Sf-9 cells by immunofluorescence and electron microscopy. Immunofluorescent staining revealed that the ADV antigen was located in the nucleus of the infected Sf-9 cells (Fig. 5) but that no such antigen could be detected in uninfected cells. Thin sections prepared from AcADVl-infected Sf-9 cells contained large numbers of 23-25-nm icosahedral virion-like particles located within the nucleus that were identical morphologically to the particles illustrated in Fig. 6 . Baculovirus particles in various stages of assembly were also noted.
These results indicated that the parvoviral antigen was transported to the nucleus and suggested that the nuclear transport signals embedded in the ADV capsid protein sequence were functional in the insect cells. In addition, the fact that parvovirus-like particles were observed in thin sections suggested that the ADV capsid proteins were self-assembling.
Self-assembly of ADV proteins into particles.
To determine if the ADV capsid proteins expressed in AcADV-1-infected Sf-9 cells were self-assembling, lysates were prepared and purified over isopycnic CsCl density gradients. Eleven fractions ranging in density from 1.31 to 1.49 were collected and analyzed. Large quantities of capsid-like structures resembling genuine ADV virions or self-assembled particles from ADV proteins expressed in vaccinia were found in fractions with densities of 1.32-l.33 g/ml. SDS-PAGE and staining by coomassie blue revealed that the 85-kD protein and the smaller 60-kD and 30-kD species could be discerned in the same fractions. WIA indicated that the ADV-specific proteins were also concentrated in the 1.32-l.33-g/ml region of the gradient. Thus, as in the vaccinia system, ADV capsid proteins expressed in baculovirus self-assembled into virus-like structures with physicochemical characteristics similar to that of native ADV virions (Fig. 6 ).
Evaluation of the antigenicity of baculovirus-expressed VP1 and VP2. Further evaluation of the antigenicity of the recombinant ADV protein was made by WIA of a panel of mink sera collected before and after infection with ADV. The ADV antibody titers of these sera were previously determined by CIE and expressed as log,. The results of this experiment are summarized in Table 1 .
No antibody specific for recombinant VP1 and VP2 was detected by WIA in sera collected from 16 mink prior to ADV infection. Antibody specific for these recombinant proteins was detected by WIA in all 10 sera with CIE titers >4. WIA also detected antibody to the recombinant proteins in 2 of 6 (33.3%) sera that had CIE titers of 4 and in 1 of 14 (7%) sera that had CIE titers of <4.
Discussion
The objective of this study was to determine if a 2.3kb cDNA that represented ADV capsid proteins VP1 and VP2 could be expressed in a highly antigenic form by the baculovirus expression system. Expression was accomplished by inserting the cDNA into the polyhedrin gene of the baculovirus AcNPV. Successful insertion and expression was indicated by the absence of the 29-kD polyhedrin protein in lysates of Sf-9 cells that were infected with the recombinant baculovirus, AcADV-1 (Fig. 3 ) and the concurrent presence in this lysate of 2 ADV-specific proteins that comigrated with native 85-kD VP1 and 75-kD VP2 (Fig. 4) . Fluorescent microscopic studies of AcADV-1-infected Sf-9 cells revealed that recombinant viral ADV proteins were located in the cell nucleus (Fig. 5) . Electronmicroscopic studies revealed that these proteins self-assembled in the cell nucleus into structures that resembled native ADV capsids (Fig. 6) . The buoyant density of these particles was 1.32-l.33 g/ml, which corresponds to the density of empty ADV capsids.
Analysis by SDS-PAGE of Sf-9 cells infected with the recombinant baculovirus also suggested that VP1 was produced in larger quantities than VP2, as indicated by the relative densities of the 2 bands representing these proteins (Fig. 4) . Greater production of VP by recombinant vaccinia has been reported. 9 However, VP2 is the predominant capsid protein in mammalian cells infected with wild-type ADV. 9 The above findings confirm previous observations from a study in which a baculovirus vector was used to express ADV proteins 8 WIA demonstrated the potential usefulness of the baculovirus recombinant ADV protein ( Table 1) . None of the 16 sera that were collected from mink prior to infection reacted with either VP1 or VP2. The overall agreement between CIE, which utilized commercially available test antigen prepared from ADV-infected mammalian cells, and WIA was 100% when sera with CIE titers >4 (log 2 ) were assayed. However, when all sera from infected mink were assayed by CIE and WIA, the percent agreement between the 2 tests was only 43.3%. This relatively low agreement value can be attributed to differences in test sensitivity or differences between the natural and the recombinant proteins that were used to test antigens.
Recombinant ADV protein is recognized immunologically by ADV-infected mink which indicates its potential usefulness as a diagnostic antigen and justifies additional studies in which native, vaccinia-expressed, and baculovirus-expressed ADV capsid proteins can be compared for efficacy and economy by the same serologic test. In a recent study 9 in which native and vaccinia recombinant VP1 and VP2 were compared by CIE, 2 of 4 mink tested positive 10 days postinfection when recombinant antigen was used in the assay but none of the 4 mink tested positive when commercially available antigen was used. Furthermore, the CIE titers of 4 mink tested at 60 days postinfection were 4-fold greater when vaccinia recombinant protein was used in the test than when commercially available nonrecombinant ADV protein was used. These results suggested that recombinant vaccinia capsid proteins were as efficacious as their native counterparts when used as diagnostic antigens. Future studies will reveal if recombinant baculovirus ADV capsid protein will also be as efficacious as native viral protein and whether or not the relatively cumbersome CIE can be replaced with an automated enzyme-linked immunosorbent assay that would utilize recombinant baculovirus ADV capsid protein as antigen.
